Quality in pharmacovigilance systems
|
|
- Andrew Bates
- 8 years ago
- Views:
Transcription
1 Quality in pharmacovigilance systems June 20 th, 2014 Lisa Stagi, Medical Compliance Leader Roche Spa Quality systems in pharmacovigilance: legal requirements Regulation 1235/2010 e Directive 2010/84 Legal basis Regulation 520/2012 Minimum requirements for quality systems for carrying out the pharmacovigilance activities GVP Modulo I PV Systems and their Quality Systems 1
2 Quality systems in pharmacovigilance: legal requirements Consistency with principles in ISO standards ISO 9000 standard for quality management systems implementation defines: - How an organization manages process in a quality framework - How to manage compliance to defined requirements - How to manage customer satisfaction - A set to aim at continuous improvement (ISO 9004) What is quality and quality management system? 2
3 Definition of Quality Management Quality is: The degree to which a set of inherent characteristics fulfills requirements According to the ISO 9000 standard A Quality Management system is defined as: The organizational structure, responsibilities, procedures, processes and resources for implementing quality management According to US FDA 21 CFR 820 Definition of Quality Management System (QMS) Framework and mindset at same time It is a framework that sets out the structure, responsibilities and procedures that help us identify, measure, control and enhance core business processes The goal of a QMS is to maintain compliance and improve business performance. It is composed by different elements interconnected QMS is the difference between excellence and disaster 3
4 A mature GVP QMS includes 5 elements... Implemented both at a Global level and at Affiliate level Communication links between Global and local functions The cycle assures continuous improvement 7 QMS Framework Strategy & Governance Strategic direction and principles that demonstrates Roche s commitment to operate in a compliant way and is dedicated to continuous improvement Organisational Effectiveness Organisation that is structured in a clear way and is well resourced with people that are capable and trained to perform their activities Processes and Procedures Policies, SOPs, work instructions, processes and training materials that enables the business to be correctly skilled and compliant Records Objective evidence and associated network of IT systems, documentation and tools to collect, process, manage and store all data associated with GCP/GVP Continuous Improvement Process by which Roche continually improves the effectiveness of our procedures and overarching QMS 8 4
5 QMS Core Documents GCP/ GVP QMS Manual The fundamental document that summarises the content of the QMS framework Strategy & Governance Organisation Effectiveness Regular management reviews to assess Quality performance Clearly defined roles, job descriptions and training documented for all individuals GCP/ GVP Quality Plan Operational tool designed to oversee the implementation of the Quality Manual (updated annually) Processes & Procedures Record Continuous Improvement Standardized and simplified processes and SOPs across the organisation GVP documents stored in structured and easily accessible compliant systems Opportunities for improvement are identified through regular review of metrics & targets (KPI management and monitoring) 9 Strategy & Governan ce Regular management reviews to assess Quality System performance in order to provide management with adequate information Periodic assignment and review of quality objectives Governance model maps and charters 10 5
6 Organisatio n Effectivene ss Clearly defined roles, job descriptions and training documented for all individuals - QPPV with sufficient authority to affect the operation in the quality system and the activity of pharmacovigilance - organization chart and clear definition of roles and responsibilities (function in charge of PV system implementation and oversight, execution, audit activities) - job descriptions with description of main role responsibilities, including QPPV - defined procedures to be followed in case of emergency (back up) 11 Organisatio n Effectivene ss Clearly defined roles, job descriptions and training documented for all individuals - staff competent, qualified and trained, (documented way) including QPPV - initial and continuing training, documented - reliable and updated training records - Training efficacy 12 6
7 The marketing authorization holder has the responsibility to ensure that in relation to outsourced activities is applied to an effective system of quality Organisatio n Effectivene ss importance of procedures on vendors management and vendor continuous oversight, in order to assure a fully compliant system: - Pharmacovigilance agreements in place - KPI defined to have oversight of vendor activities - Audit plan 13 Process es & Procedu res Standardized and simplified processes and SOPs across the organization - continuous monitoring of pharmacovigilance data - Risk minimization and risk prevention, managing new risks or changes to existing risks - the scientific assessment of the risks of medicines - transmission to the EudraVigilance database of accurate and verifiable data on serious and non-serious adverse reactions, according to the timing defined by regulation - SOPs to guarantee the quality, integrity and completeness of the information provided on risks of medicines - To avoid double reporting - For validation of the signals 14 7
8 Standardized and simplified processes and SOPs across the organization Process es & Procedu res - effective communication with the competent Authorities - Business Continuity Plan - Managing the PSFM - Management of PSUR - Corrective and preventive actions - Post-authorization safety studies - the updating of product information - Safety management during clinical trials - Adequate provision of information relevant to safety to health professionals and patients 15 GCP / GVP documents are stored in structured and easily accessible compliant systems Record - Recording all the information of PV, handled and stored in such a way they can be reported, interpreted and verified thoroughly - Pharmacovigilance data and documents relating to individual medicines authorized preserved as required - Records management system for all documents used for pharmacovigilance activities in order to: Find these documents Track how and when were examined / made decisions on safety issues - Tracking and follow-up of adverse reaction reports - Keeping the elements of the PSFM according to law requirements 16 8
9 Continuous Improveme nt Opportunities for improvement are identified through regular review of metrics & targets (KPI management and monitoring) Periodic review of Quality Plans Implement Quality Monitoring ( routine sourvellaince of activities performed through Quality Control and Quality Assurance activities) 17 Quality Control activities Continuo us Improve ment - Double check activities and quality control plan for more relevant processes (IRT collection, RMP ) - Monitoring of process performance through KPI, regularly collected and reviewed -KPI identified based on the main attributes of processes (in terms of accuracy, consistency, completeness and medical adherence) dashboard developed to be considered by senior management. - KPI out of control subject to CAPA (Corrective & Preventative) management 18 9
10 Quality Assurance activities Continuo us Improve ment Audit - Periodic audits based on risk and process analysis, with a defined audit plan to ensure compliance with quality system requirements described to determine the effectiveness outsourced activities covered by audit plan - Audits carried out by people who do not have responsibility or implications Independent auditors required (Quality Assurance function) - Documented reports and follow up 19 Quality Assurance activities Continuo us Improve ment CAPA management - Defined SOPs to track, manage and periodically review corrective and preventative actions, to be reported to senior management in management review - Deviation management 20 10
11 Quality is not an act, it s a habit Aristotile Our approach to QMS Fully engrained quality in the organization Systems & Processes GxP Process Business Process Capabilities Skills Knowledge Experience Education Training Mindset Accountability Proactive Thinking Commitment Robust business processes & systems Process capability/ KPIs Leadership & business acumen Qualified Staff Compliance sustainability & proactive risk management Quality owned by all 11
12 Most importantly: Keep it Simple! 23 Grazie per l attenzione 12
Seminario SSFA. New Guideline on Good Pharmacovigilance Practice (GVP) Fare clic per modificare lo stile del sottotitolo dello schema
Seminario SSFA New Guideline on Good Pharmacovigilance Practice (GVP) Pharmacovigilance Systems and their Quality Systems Milano, 20th April 2012 GIULIA M. VALSECCHI The proposed GVP - Module 1 Guidance
More informationGuideline on good pharmacovigilance practices (GVP)
1 2 20 February 2012 EMA/541760/2011 3 4 Guideline on good pharmacovigilance practices (GVP) Module I Pharmacovigilance systems and their quality systems Draft finalised by the Agency in collaboration
More informationGuideline on good pharmacovigilance practices (GVP)
9 April 2013 EMA/816573/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module II Pharmacovigilance system master file (Rev 1) Draft of first version finalised by the Agency in collaboration
More informationGuideline on good pharmacovigilance practices (GVP)
22 June 2012 EMA/541760/2011 Guideline on good pharmacovigilance practices (GVP) Module I Pharmacovigilance systems and their quality systems Draft finalised by the Agency in collaboration with Member
More informationDetailed guidance AEs reporting in clinical trials ( CT-3 ) Stefano Bonato, M.D. Pharmacovigilance Country Head Bayer HealthCare Pharmaceuticals
Detailed guidance AEs reporting in clinical trials ( CT-3 ) Stefano Bonato, M.D. Pharmacovigilance Country Head Bayer HealthCare Pharmaceuticals Pharmacovigilance costs 0.12%-0.22% of hospital admissions
More informationPharmacovigilance System Master File (PSMF), QPPV and audits
Federal Agency for Medicines and Health Products (FAMHP) Pharmacovigilance System Master File (PSMF), QPPV and audits Matthijs Nele, PhV Inspector, DG Inspection BRAS - FAMHP/NM/ 1 Content Introduction
More informationThe Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor
The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality
More informationComplacency is not an Option
Complacency is not an Option Frank Deane, Ph.D., President, Global Manufacturing, Eli Lilly and Company 2 Agenda Lilly s manufacturing quality transformation journey Lilly s quality system Control strategy
More informationTHE SCHOOL DISTRICT OF PHILADELPHIA
No. 009 THE SCHOOL DISTRICT OF PHILADELPHIA SECTION: TITLE: SCHOOL REFORM COMMISSION OPERATIONS OVERSIGHT ADOPTED: October 5, 2011 REVISED: 009. OPERATIONS OVERSIGHT Section 1. Purpose SC 696 Pol. 003
More informationEudraVigilance stakeholder change management plan
26 October 2015 EMA/797114/2014 Information Management Division Consultation of Project Maintenance Group 1 15 July 2015 Consultation of Eudravigilance Expert Working Group 23 September 2015 Consultation
More informationGap Analysis of the Change Control Process The History of a Transformed Change Control System
Gap Analysis of the Change Control Process The History of a Transformed Change Control System Juan Alcazar Quality Systems Carolina, PR Content Introduction Gap Analysis Phases to perform a Gap Analysis
More informationData Governance Planning PDA 12 May 2015
Data Governance Planning PDA 12 May 2015 1 Agenda Overview of Data Integrity Assurance of Data Data Governance The Data Governance Plan Questions 2 Overview of Data Integrity 3 Data Information derived
More informationReport to the European Commission on Pharmacovigilance audits carried out in the Medicines Evaluation Board, The Netherlands period of time from
Report to the European Commission on Pharmacovigilance audits carried out in the Medicines Evaluation Board, The Netherlands period of time from September 2013 to September 2015 1. INTRODUCTION Applicable
More informationMarie-Claire Rickard, GCP & Governance Manager Rachel Fay, GCP & Governance Manager Elizabeth Clough, R&D Operations Manager
Standard Operating Procedures (SOP) for: Monitoring SOP 28 Version 7.0 Number: Number: Effective Date: 29 th November 2015 Review Date: 6 th January 2017 Author: Reviewer: Reviewer: Authorisation: Name
More informationQUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH
QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing
More informationDiscussion Paper on the Validation of Pharmacovigilance Software provided via SaaS
Discussion Paper on the Validation of Pharmacovigilance Software provided via SaaS June 2012 K Edmonds Page 1 of 10 Page 2 of 10 Contents 1. Introduction... 4 2. Quality Statement ISO 9001:2008... 4 3.
More informationBarnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA This presentation is the property of DynPort Vaccine Company LLC, a CSC company, and
More informationComparison of EU-Pharmacovigilance System Master File (PSMF) with US System
Comparison of EU-Pharmacovigilance System Master File (PSMF) with US System Wissenschaftliche Prüfungsarbeit Zur Eralngung des Titels Master of Drug Regulatory Affairs der Mathematisch-Naturwissenschaftlichen
More informationISO 9000 Introduction and Support Package: Guidance on the Documentation Requirements of ISO 9001:2008
Document: ISO/TC 176/SC 2/N 525R2 ISO 9000 Introduction and Support Package: 1 Introduction Two of the most important objectives in the revision of the ISO 9000 series of standards have been a) to develop
More informationServices Providers. Ivan Soto
SOP s for Managing Application Services Providers Ivan Soto Learning Objectives At the end of this session we will have covered: Types of Managed Services Outsourcing process Quality expectations for Managed
More informationThe role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations
The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations Maria Luisa Paoloni OPBG Clinical & Research Services Monitoring and Responsible of monitoring:
More informationWorkshop on Quality Risk Management Making Trials Fit for Purpose
Clinical Trials Transformation Initiative Workshop on Quality Risk Management Making Trials Fit for Purpose Andy Lee SVP, Global Clinical Operations, Genzyme Corporation August 23/24, 2011 Hyatt Regency,
More informationMedical Information and Pharmacovigilance through acquisition. Lisa Hughes Medical Affairs Manager Actavis UK Ltd
Medical Information and Pharmacovigilance through acquisition Lisa Hughes Medical Affairs Manager Actavis UK Ltd Disclaimer The views and opinions expressed in the following presentation are those of the
More informationQuestions & answers on signal management
23 October 2015 EMA/261758/2013 Inspections and Human Medicines Pharmacovigilance Division This document addresses a number of questions which stakeholders, in particular marketing authorisation holders
More informationData Management Unit Research Institute for Health Sciences, Chiang Mai University
Data Management Unit Research Institute for Health Sciences, Chiang Mai University Clinical Data Management is the process of handling data from clinical trials. The inherent goal of any clinical data
More informationStakeholder Meeting, 7 th June 2013 An inspector s perspective considerations for patient support and reimbursement programmes
Stakeholder Meeting, 7 th June 2013 An inspector s perspective considerations for patient support and reimbursement programmes Dr Anya Sookoo, Expert Inspector, Inspections, Enforcement & Standards Division,
More informationGuidance notes. for Patient Safety and Pharmacovigilance in Patient Support Programmes
Guidance notes for Patient Safety and Pharmacovigilance in Patient Support Programmes 9 May 2011 Approval Status Authors The ABPI Pharmacovigilance Expert Network Change History N/A Approval Date 9 May
More informationFrom paper to electronic data
From paper to electronic data Bioindustrypark, October 10, 2013 Dr Alessandra Grande Ivrea GxP Test Facility QA Manager, Head Global BMT QA Research & Development Quality Assurance MerckSerono RBM Outline
More information4Sight Calibration Management Software
GE Measurement & Control Solutions 4Sight Calibration Management Software 4Sight calibration and maintenance management software provides visibility to the assets, data, and resources that affect maintenance,
More informationAgence fédérale des médicaments et des produits de santé
Agence fédérale des médicaments et des produits de santé From Risk Management Plan to Risk Minimization Activities New Royal Decree: Status and General Explanation Role of the Pharmacovigilance Department
More informationDAIDS Bethesda, MD USA. POLICY Requirements for Clinical Quality Management Plans
CHANGE SUMMARY: This policy and associated appendices have been reviewed for accuracy and updated to meet 508 compliance guidelines. Key changes to the policy require all sites to submit a bi-annual Clinical
More informationAccenture Accelerated R&D Services:
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Accenture Accelerated R&D Services: Pharmacovigilance Services Overview At our company, we are focused on improving lives
More informationImplementing an ISO 9001 Quality Management System
Implementing an ISO 9001 Quality Management System ETI Group This guide to implementing an ISO 9001 Quality Management System (QMS) was prepared by ETI Group. The guide is based on our experiences assisting
More informationThe EMA current activities towards ISO IDMP implementation
The EMA current activities towards ISO IDMP implementation An overview Ginas meeting 11 June 2014 Presented by: Ilaria Del Seppia, B-BD-DCM EMA An agency of the European Union Outlines EMA Vision: Objectives
More informationPHARMACEUTICAL QUALITY SYSTEM Q10
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step
More informationU.S. Food and Drug Administration
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained
More information340B University Page 1 340B Manager and Coordinator Job Description Template
340B University Page 1 Purpose: The purpose of this tool is to provide a list of activities commonly assigned to the role of 340B Manager or Coordinator. This list is not exhaustive, rather a compilation
More informationICH guideline Q10 on pharmaceutical quality system
September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final
More informationThe Paperless QMS March 2012
The Paperless QMS March 2012 Overview Introductions What do we mean by Paperless QMS? Short history of the (pharma) Paperless QMS What do you need your Paperless QMS to do? Practical application and considerations
More informationCLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]
CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CONTRACT RESEARCH ORGANIZATION SPONSOR [NAME] [ADDRESS] 1 TABLE OF CONTENTS 1. Purpose 3 2. References 3 3. Study Roles and Responsibilities
More informationUNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE
UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES University of Leicester (UoL)
More informationAligning Quality Management Processes to Compliance Goals
Aligning Quality Management Processes to Compliance Goals MetricStream.com Smart Consulting Group Joint Webinar February 23 rd 2012 Nigel J. Smart, Ph.D. Smart Consulting Group 20 E. Market Street West
More informationRisk based monitoring using integrated clinical development platform
Risk based monitoring using integrated clinical development platform Authors Sita Rama Swamy Peddiboyina Dr. Shailesh Vijay Joshi 1 Abstract Post FDA s final guidance on Risk Based Monitoring, Industry
More informationGuidance for Industry. Q10 Pharmaceutical Quality System
Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation
More informationGCP - Records Managers Association
GCP - Records Managers Association Guidance on the Scanning and Destruction of Paper Records 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 The introduction
More informationImplementation strategy for ISO IDMP in EU
Implementation strategy for ISO IDMP in EU Paolo Alcini Head of Data Standardisation and Analytics Business Data & Analytics Information Management EMA An agency of the European Union The EU ISO IDMP Task
More informationMonitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency
28 August 2015 EMA/386784/2015 Inspections and Human Medicines Pharmacovigilance Division Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the
More informationCamber Quality Assurance (QA) Approach
Camber Quality Assurance (QA) Approach Camber s QA approach brings a tested, systematic methodology, ensuring that our customers receive the highest quality products and services, delivered via efficient
More informationPHARMACOVIGILANCE IN A BOX
PHARMACOVIGILANCE IN A BOX Evolution of Pharmacovigilance Over the years the role of Pharmacovigilance or Product Vigilance (PV) has changed from capturing and reporting adverse events to a business imperative
More informationReport to the European Commission on Pharmacovigilance audits carried out in the Medicines Evaluation Board, The Netherlands period of time from July
Report to the European Commission on Pharmacovigilance audits carried out in the Medicines Evaluation Board, The Netherlands period of time from July 2012 to September 2013 1. INTRODUCTION Applicable legislation:
More informationManaging & Validating Research Data
Research Management Standard Operating Procedure ISOP-H02 VERSION / REVISION: 2.0 EFFECTIVE DATE: 01 03 12 REVIEW DATE: 01 03 14 AUTHOR(S): CONTROLLER(S): APPROVED BY: Information Officer; NBT Clinical
More informationGLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com
GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process
More informationStandard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s. Lisa Austin, Research Manager
Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s Author: Lisa Austin, Research Manager Purpose and Objective: To identify and standardise
More informationLIBRARY GUIDE: Clinical Medical Device
LIBRARY GUIDE: Clinical Medical Device Table of Contents Overview... 3 Clinical Curriculum Core Program Course Descriptions: A Tour of Health Canada (PHDV89)...5 A Tour of Health Europe (PHDV90)...5 A
More informationNo. 706. Page 1 of 5. Issue Date 4/21/2014
Subject: ROUTINE MONITORING VISITS Standard Operating Procedure Prepared By: Beaumont Research Coordinating Center, Research Institute PURPOSE Prior Issue Date 8/15/2011 No. 706 Issue Date 4/21/2014 Page
More informationComplianceSP TM on SharePoint. Complete Document & Process Management for Life Sciences on SharePoint 2010 & 2013
TM ComplianceSP TM on SharePoint Complete Document & Process Management for Life Sciences on SharePoint 2010 & 2013 Overview With increasing pressure on costs and margins across Life Sciences, the industry
More informationEMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART Framework Labs generate data that are used to make decisions on the safety and efficacy of medicinal products; consequently,
More informationCOMMUNICATIONS MANAGEMENT PLAN <PROJECT NAME>
COMMUNICATIONS MANAGEMENT PLAN TEMPLATE This Project Communications Management Template is free for you to copy and use on your project and within your organization. We hope that you find this template
More informationTHE ACTIVITIES AND FUTURE DEVELOPMENT OF GCP INSPECTIONS IN TANZANIA
THE ACTIVITIES AND FUTURE DEVELOPMENT OF GCP INSPECTIONS IN TANZANIA Godwin D. Ndossi, PhD Chairman Tanzania National Health Research Forum Formerly, Managing Director Tanzania Food and Nutrition Centre
More informationEstablishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)
Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Cornelia Kamp, MBA Executive Director Strategic Initiatives Tim Hackett Director
More informationWhat changes will ISO 9001:2015 bring?
What changes will ISO 9001:2015 bring? 1 Introduction This presentation will cover the following topics: The ISO 9001 Revision Process Key Inputs to ISO 9001:2015 The High Level Structure Key Changes in
More informationWhat is the correct title of this publication? What is the current status of understanding and implementation?
GMP Rules and Guidelines in 2013 for Computer System Validation / Computerises Systems / Electronic Records and Signatures/ IT Infrastructure and Application Compliance: What is the correct title of this
More informationStudy Start-Up SS-204.01. STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)
Study Start-Up SS-204.01 STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV) Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval: Frederick M. Schnell,
More informationHealth Care Job Information Sheet #20. Clinical Research
Health Care Job Information Sheet #20 Clinical Research A. Background B. Occupations 1) Clinical Research Associate (Study Monitor) 2) Clinical Research Coordinator 3) Other positions in the field C. Labour
More informationORACLE CONSULTING GROUP
ORACLE CONSULTING GROUP 9 Golder Ranch Rd., Ste. 1 Tucson, Arizona 9 Web Site: E-mail: 20-2-0 20-2-0 (FAX) CONSULTING MEMORANDUM QUALITY SYSTEM INSPECTION TECHNIQUE
More informationHow Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program
How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program Presenter: Jan Holladay Pierre, MPH Quality Principal Leader DynPort Vaccine Company LLC, A CSC Company This presentation
More informationOne-year report on human medicines pharmacovigilance tasks of the European Medicines Agency
8 April 2014 EMA/171322/2014 Pharmacovigilance Department One-year report on human medicines pharmacovigilance tasks of the European Medicines Agency Reporting period: 2 July 2012 to 1 July 2013 7 Westferry
More informationEmpowering the Quality and Regulatory Compliance Functions
Empowering the Quality and Regulatory Compliance Functions Management must take steps to ensure that regulatory and quality compliance is everyone s responsibility. By: J. Glenn George, Kenneth Imler,
More informationREGULATORY REQUIREMENTS OF PHARMACOVIGILANCE SYSTEM AND ITS COMPARISON IN INDIA AND USA
ISSN: 2230-7346 Krupa C. Thula et al. / JGTPS / 6(1)-(2015) 2351 2356 (Review Article) Journal of Global Trends in Pharmaceutical Sciences Journal home page: www.jgtps.com REGULATORY REQUIREMENTS OF PHARMACOVIGILANCE
More informationII. Compliance Examinations - Compliance Management System. Compliance Management System. Introduction. Board of Directors and Management Oversight
Compliance Management System Introduction Financial institutions operate in a dynamic environment influenced by industry consolidation, convergence of financial services, emerging technology, and market
More informationCLINICAL RESEARCH GENERIC TASK DESCRIPTIONS
Purpose Purpose Purpose Primary responsibility for implementation, coordination, evaluation, communication and/or management of research studies. May involve more than one study or multiple sites within
More informationCamar Aircraft Products Co. QUALITY MANUAL Revision D
QUALITY MANUAL Revision D Gujll'y Manual Introduction The purpose of this manual is to describe the Quality Assurance Program implemented by Camar Aircraft Products Co. (hereafter referred to as C.A.P.C.)
More informationTask Manager. Task Management
Task Management ibpms Business Process Applications (BPAs) are the innovative, new class of Service Oriented Business Applications (SOBAs) that help businesses automate and simplify the management of missioncritical,
More informationCOMMUNIQUE. Information Technology (IT) Governance Guidance
COMMUNIQUE 14-COM-002 July 14, 2014 Information Technology (IT) Governance Guidance The Credit Union Prudential Supervisors Association (CUPSA) has established an IT Risk Working Group to focus on IT governance
More informationRisk Management Plan - Bayer Experience :
Risk Management Plan - Bayer Experience : Organization & Processes Najoua ADYEL Pharmacovigilance Country Head Maghreb Introduction: Pharmacovigilance toward maturity 50 s and 60 s: from nothing to reacting
More informationNew Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01)
Safeguarding public health New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Tony Orme, Senior GDP Inspector Inspection, Enforcement and Standards Division
More informationQUALITY MANAGEMENT SYSTEM REQUIREMENTS General Requirements. Documentation Requirements. General. Quality Manual. Control of Documents
Chapter j 38 Self Assessment 729 QUALITY MANAGEMENT SYSTEM REQUIREMENTS General Requirements 1. Establishing and implementing a documented quality management system 2. Implementing a documented quality
More informationQuality Agreements: Contractual Commitments by CROs to Deliver High-Quality Work
Vol. 10, No. 11, November 2014 Happy Trials to You Quality Agreements: Contractual Commitments by CROs to Deliver High-Quality Work By Tom McGrady and Susan Callery-D Amico Introduction Regulated companies
More informationManaging quality in clinical trials is the focus of daily activities that,
This article describes a targeted review of a quality management system that provides the organization with the inherent ability to identify, analyze, and address possible performance issues through the
More informationEphMRA Adverse Event Reporting Guidelines 2015
EphMRA Adverse Event Reporting Guidelines 2015 Based upon the Guideline on good pharmacovigilance practices (GVP) Module VI Management and reporting of adverse reactions to medicinal products European
More informationWE ANSWER QUESTIONS THAT NO ONE ELSE CAN. 68 T.W. Alexander Dr. P.O. Box 13628 Research Triangle Park, NC 27709 www.cuttingedgeinfo.
MEDICAL INFORMATION AND CALL CENTER PERFORMANCE BUILDING NEW PRACTICES TO MEET THE EVOLVING NEEDS OF HCPS AND PATIENTS FULL TABLE OF CONTENTS & CHARTS AND GRAPHICS 68 T.W. Alexander Dr. P.O. Box 13628
More informationQuality Management in Clinical Trials
CLINICAL CASE STUDY SERIES Quality Management in Clinical Trials Clinical trials are conducted to collect the data necessary to provide information for academia, industry, and regulators to make decisions
More informationTitle:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions
WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing
More informationValidation Consultant
Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 172 737 84 86 E-Mail: Internet: jsb-val@online.de http://www.jsb-validierung.de
More informationWHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE
WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE White paper produced by Maetrics For more information, please contact global sales +1 610 458 9312 +1 877 623 8742 globalsales@maetrics.com
More informationGuidance notes on the management of adverse events and product complaints from digital media
Guidance notes on the management of adverse events and product complaints from digital media Guidance notes on the management of adverse events and product complaints from digital media ABPI Pharmacovigilance
More informationFINANCIAL ASSESSMENT CRITERIA (The Assessment Criteria should be read in conjunction with OSFI s Supervisory Framework)
ROLE OF Financial is an independent function responsible for ensuring the timely and accurate reporting and in-depth analysis of the operational results of the operating units (including business lines)
More informationGood practice guide on recording, coding, reporting and assessment of medication errors
1 2 3 14 April 2015 EMA/762563/2014 Pharmacovigilance Risk Assessment Committee (PRAC) 4 5 6 Good practice guide on recording, coding, reporting and assessment of medication errors Draft Draft finalised
More informationCentral Project Office: Charter
Central Project Office: Charter ITCS: Central Project Office EAST CAROLINA UNIVERSITY 209 COTANCHE STREET, GREENVILLE, NC 27858 1 Table of Contents INTRODUCTION... 3 PURPOSE... 3 EXPECTED BENEFITS... 3
More informationASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 038-1 26 March 2012 AIDE-MEMOIRE ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PIC/S March 2012 Reproduction
More informationPharmaceutical Quality & Clinical Research Quality: The Interaction
4 th Jerusalem Conference: Quality by Design (QbD)) & Pharma Sciences, May 20-22, 2014 The Edmund Safra Campus, The Hebrew University of Jerusalem Pharmaceutical Quality & Clinical Research Quality: The
More informationGuideline on good pharmacovigilance practices (GVP)
19 April 2013 EMA/813938/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VIII Post-authorisation safety studies (Rev 1) Draft of first version finalised by the Agency in collaboration
More informationThe Global Guideline for GCP Audit
The Global Guideline for GCP Audit Author: JSQA: Hiroyasu Yamashita, e-mail: hiroyasu-yamashita@ds-pharma.co.jp Reviewed and Acknowledged by: BARQA: Patricia Fitzgerald, e-mail: Patricia.fitzgerald@adamas.co.uk
More informationData & Analytics in Internal Audit. January 13, 2015
Data & Analytics in Internal Audit January 13, 2015 With You Today KPMG Brian Greenberg, Director, Data & Analytics-enabled Internal Audit (National) Sean Mulyanto, Manager IT Advisory (Los Angeles) 1
More informationCompetentes en Medicamentos
VIII Encuentro de Autoridades Competentes en Medicamentos de los Países Iberoamericanos (EAMI) 12-14 de Mayo 2010 Madrid MARTIN TERBERGER Jefe de la Unidad de Productos Farmacéuticos Nuevas iniciativas
More informationMedical Device Training Program 2015
Medical Device Training Introduction Supplementary training and education is often overlooked by medical device professionals until it is triggered by an upcoming FDA or Notified Body and/or ISO 13485
More informationAPPENDIX 50. Enterprise risk management - Risk management overview
APPENDIX 50 Enterprise risk management - Risk management overview Energex regulatory proposal October 2014 ENTERPRISE RISK MANAGEMENT Risk Management Overview (RMO) 06 11 2013 Table of Contents 1. INTRODUCTION...
More informationData submission of authorised medicines in the European Union
23 February 2015 EMA/471367/2014, Rev. 1 1 Business Data and Support Department Data submission of authorised medicines in the European Union Outlines on Article 57(2) of Regulation (EC) No 726/2004 1
More informationCloud Vendor Evaluation
Cloud Vendor Evaluation Checklist Life Sciences in the Cloud Cloud Vendor Evaluation Checklist What to evaluate when choosing a cloud vendor in Life Sciences Cloud computing is radically changing business
More informationInternal Audit Strategic and Annual Plans 2015/16
Internal Audit Strategic and Annual Plans 2015/16 Financial Scrutiny and Audit Committee 10 February 2015 Agenda Item No 8 Summary: This report provides an overview of the stages followed prior to the
More information